LPAR6

Origem: Wikipédia, a enciclopédia livre.
Ir para: navegação, pesquisa

No campo da biologia molecular, o receptor de ácido lisofosfatídico, também conhecido como LPA6 e P2RY5, é uma proteína que pertence ao grupo dos receptores P2Y e que, em seres humanos, é codificada pelo gene LPAR6.[1] [2] [3]

Referências

  1. Adrian K, Bernhard MK, Breitinger HG, Ogilvie A. (Sep 2000). "Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells". Biochim Biophys Acta 1492 (1): 127–38. PMID 11004484.
  2. Ralevic V, Burnstock G. (Nov 1998). "Receptors for purines and pyrimidines". Pharmacol Rev 50 (3): 413–92. PMID 9755289.
  3. Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, Ishii S. (Jun 2009). "Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6". J Biol Chem 284 (26): 17731–41. DOI:10.1074/jbc.M808506200. PMID 19386608.

Leitura de apoio[editar | editar código-fonte]

  • Toguchida J, McGee TL, Paterson JC, et al.. (1993). "Complete genomic sequence of the human retinoblastoma susceptibility gene.". Genomics 17 (3): 535–43. DOI:10.1006/geno.1993.1368. PMID 7902321.
  • Maruyama K, Sugano S. (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. DOI:10.1016/0378-1119(94)90802-8. PMID 8125298.
  • Herzog H, Darby K, Hort YJ, Shine J. (1997). "Intron 17 of the human retinoblastoma susceptibility gene encodes an actively transcribed G protein-coupled receptor gene.". Genome Res. 6 (9): 858–61. DOI:10.1101/gr.6.9.858. PMID 8889552.
  • Li Q, Schachter JB, Harden TK, Nicholas RA. (1997). "The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses.". Biochem. Biophys. Res. Commun. 236 (2): 455–60. DOI:10.1006/bbrc.1997.6984. PMID 9240460.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al.. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. DOI:10.1016/S0378-1119(97)00411-3. PMID 9373149.
  • Strausberg RL, Feingold EA, Grouse LH, et al.. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T, et al.. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. DOI:10.1038/ng1285. PMID 14702039.
  • Dunham A, Matthews LH, Burton J, et al.. (2004). "The DNA sequence and analysis of human chromosome 13.". Nature 428 (6982): 522–8. DOI:10.1038/nature02379. PMID 15057823.
  • Gerhard DS, Wagner L, Feingold EA, et al.. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMID 15489334.
  • Ihara H, Hirukawa K, Goto S, Togari A. (2005). "ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts.". Biochem. Biophys. Res. Commun. 326 (2): 329–34. DOI:10.1016/j.bbrc.2004.11.037. PMID 15582581.
Ícone de esboço Este artigo sobre Biologia molecular é um esboço. Você pode ajudar a Wikipédia expandindo-o.